COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2.
FactSnippet No. 1,424,623 |
COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2.
FactSnippet No. 1,424,623 |
Individual jurisdictions have adopted varied COVID-19 testing protocols, including whom to test, how often to test, analysis protocols, sample collection and the uses of test results.
FactSnippet No. 1,424,624 |
Rapid self-tests and point-of-care COVID-19 testing are available and can offer a faster and less expensive method to test for the virus although with a lower accuracy.
FactSnippet No. 1,424,625 |
COVID-19 testing can be identified with higher precision using CT than with RT-PCR.
FactSnippet No. 1,424,626 |
Shortages of reagent and other COVID-19 testing supplies became a bottleneck for mass COVID-19 testing in the EU, the UK and the US.
FactSnippet No. 1,424,627 |
Pooled COVID-19 testing can improve turnaround time, by combining a number of samples to be tested together.
FactSnippet No. 1,424,628 |
Pool COVID-19 testing was then adopted in Israel, Germany, Ghana South Korea, Nebraska, China and the Indian states of Uttar Pradesh, West Bengal, Punjab, Chhattisgarh and Maharashtra.
FactSnippet No. 1,424,629 |
COVID-19 testing tends to grow exponentially at the beginning of an outbreak, meaning that the number of required tests initially grows exponentially.
FactSnippet No. 1,424,630 |
Summary review in BMJ has noted that while some "serological tests … might be cheaper and easier to implement at the point of care [than RT-PCR]", and such COVID-19 testing can identify previously infected individuals, "caution is warranted … using serological tests for … epidemiological surveillance".
FactSnippet No. 1,424,631 |
Korea already had a system for isolating, COVID-19 testing and treating infectious disease patients separately from others.
FactSnippet No. 1,424,633 |
Shortage of trained medical laboratory scientists, assay reagents, analyzers, transport medium, and PPE coupled with high demand had limited initially limited the availability of COVID-19 testing and led to significantly increased turnaround times.
FactSnippet No. 1,424,634 |